General Director of the Jordan Food and Drug Administration (JFDA), Nizar Mhaidat, announced that anti-COVID-19 vaccine, AstraZeneca, has been granted a permit for emergency use.
Mhaidat told the Jordan News Agency (Petra) that the AstraZeneca vaccine is the third vaccine the JFDA has approved, after Pfizer and Sinopharm vaccines.
General Director of the Jordan Food and Drug Administration (JFDA), Nizar Mhaidat, announced that anti-COVID-19 vaccine, AstraZeneca, has been granted a permit for emergency use.
Mhaidat told the Jordan News Agency (Petra) that the AstraZeneca vaccine is the third vaccine the JFDA has approved, after Pfizer and Sinopharm vaccines.
General Director of the Jordan Food and Drug Administration (JFDA), Nizar Mhaidat, announced that anti-COVID-19 vaccine, AstraZeneca, has been granted a permit for emergency use.
Mhaidat told the Jordan News Agency (Petra) that the AstraZeneca vaccine is the third vaccine the JFDA has approved, after Pfizer and Sinopharm vaccines.
comments